Analysis reveals that socio-economic status impacts mortality rates in children with congenital anomalies in Europe, suggesting urgent resource allocation for vulnerable populations.
Background Childhood mortality is affected by major congenital anomalies and socio-economic status (SES). To our knowledge, their combined impact has not been explored to age 10. Methods We analysed the population-based EUROlinkCAT cohort to ascertain the impact of SES on mortality by ages 1 and 10 amongst children with congenital anomalies in ten congenital anomaly registers in seven European countries. Four countries defined SES according to maternal education, and two used their national index of multiple deprivation. The ten registers used a common script to generate data on survival by ages 1 and 1–10 (365–3651 days). Eight registers analysed deaths according to their SES criteria, categorised as low, intermediate and high SES. Linked data were combined in random effects meta-analyses. Finland and Emilia-Romagna held data on single motherhood and EU-nationality. Results We analysed mortality in relation to SES using data on 47,134 live-born children with major congenital anomalies classified and recorded 1996–2014. Mortality by age 1 and ages 1–10 was higher amongst the most than the least deprived, hazard ratios (HR) and 95% confidence intervals (CI) 1.47, 1.19–1.83 and 2.00, 1.32–3.02. Differences between intermediate and least deprived groups were smaller. Differences were statistically significant for all four analyses only in Ukraine and Wales. Mortality rates were higher for children of non-EU nationals, but not single mothers. Implications Deprivation was more strongly associated with death at ages 1–10 than in infancy. These analyses of the most ill children in Europe indicate that, to achieve sustainable development goals, more resources are needed for the most vulnerable children.
No takes yet. Share an insight, caveat, or question.
Jordan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: